About Us

Management|

Daotian Fu, Ph.D, General Manager

Daotian Fu, Ph.D, General Manager

Daotian Fu earned his Ph.D. from  Iowa State University, USA, and completed post-doctoral training at the University of Georgia in collaboration with Harvard Medical School, Dr. Fu has been actively engaged in the development and commercialization of biologics for over 20 years. He is a distinguished expert in the China National “1000 Talents” program. Prior to joining Livzon, Dr. Fu was Vice President at Genzyme, where he was responsible for the quality control and analytical development of all biologics in development. Dr. Fu is Vice President of Livzon Pharmaceutical Group and General Manager of Livzon Mabpharm Inc.

Yucai Peng, Ph.D,Senior Vice President

Yucai Peng, Ph.D,Senior Vice President

Yucai Peng has a Ph.D from McGill University, Canada. Dr. Peng has over 15 years of biotechnology and biopharmaceutical development experience. He is a recipient of the Leading Talent award from Guangdong Province, China. Prior to joining Livzon Mabpharm Inc., he held a Senior Scientist position at Biogen-Idec. Dr. Peng is Senior Vice President of Clinical Research at Livzon Mabpharm Inc.

Ryan Wen,Ph.D,Vice President

Ryan Wen,Ph.D,Vice President

Wen Ryan received his Ph.D from Illinois Institute of Technology, Chicago, USA. He is a distinguished expert in the China National“1000 Talent” program. Prior to joining Livzon Mabpharm Inc., he served as director of the GMP manufacturing at Amgen. Dr. Ryan has been actively engaged in the development and commercialization of biologics for over 20 years. He is Vice President of Process Development and Manufacturing at Livzon Mabpharm Inc.

Weimin Dai, M.D&Ph.D, Chief Medicine Officer

Weimin Dai, M.D&Ph.D, Chief Medicine Officer

Weimin Dai received his M.D from Aarhus University, Denmark and his Ph.D from the Danish University of Pharmaceutical Sciences. Dr. Dai has 8+ years of clinical practice and reaching experience and over 19 years of experience in clinical development. He previously served in GE, GSK, Henrui Medicine. Dr. Dai is Chief Medicine Officer to Livzon Mabpharm Inc.

Changdong Liu, M.D,Vice President

Changdong Liu, M.D,Vice President

Changdong Liu received his M.D from Tongji Medical University, China. Prior to joining Livzon, he served as Clinical Lead at Novartis (USA) and Senior Vice President at Qilu Pharmaceuticals (China). He has over 20 years of clinical development experience. Dr. Liu is Vice President of Oncology Clinical Research at Livzon Mabpharm Inc.

Matthew Luo, Vice President

Matthew Luo, Vice President

Matthew Luo is skilled in quality systems design, implementation and execution. He has over twenty years of experience at the forefront of quality operations in clinical and commercial pharmaceutical and biopharmaceutical manufacturing settings. Prior to joining Livzon, Mr. Luo served at Amgen and Eli Lilly. He is Vice President of Quality Assurance at Livzon Mabpharm Inc.